LSBio bolsters antibody tech portfolio

December 23, 2020

Acquires Absolute Antibody and sister company Kerafast

LSBio, a supplier of antibodies and life science research reagents, has acquired Absolute Antibody, Ltd. and its sister company Kerafast. Terms of the deal were not disclosed.

Specifically, LSBio provides immunohistochemistry (IHC)-validated reagent antibodies and offerings to academic, pharma and biotech researchers. With more than 750,000 reagent antibodies, assay kits, proteins and biochemicals, the company’s purchase of Absolute Antibody and Kerafast further expands its product portfolio by adding an assortment of additional reagents and antibody services.

Absolute Antibody specializes in recombinant antibody technology, offering antibody sequencing, engineering and recombinant production as custom services, along with recombinant antibodies and Fc-fusion proteins, designed into new formats. In 2018, it merged with Kerafast Inc., a company that enables access to unique laboratory-made reagents, to extend the availability of recombinant antibodies.